"
Team:Paris Bettencourt/Notebook/Template.html
From 2013.igem.org
(Difference between revisions)
(Created page with "<div id ="TBNote"> <h3> Templates for a day </h3> <h4> Drug Screening </h4> <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Drug_Screen"> </a> <b> Add here your twit...") |
|||
| (44 intermediate revisions not shown) | |||
| Line 1: | Line 1: | ||
| - | < | + | <html> |
| - | < | + | <head> |
| - | < | + | <style type="text/css"> |
| - | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/ | + | #tbnote { |
| + | width: 75%; | ||
| + | overflow: auto; | ||
| + | overflow-x: auto; | ||
| + | overflow-y: auto; | ||
| + | } | ||
| + | |||
| + | #tbnote p { | ||
| + | width: 65%; | ||
| + | } | ||
| + | </style> | ||
| + | <!--<link rel="stylesheet" type="text/css" href="https://2013.igem.org/wiki/index.php?title=Team:Paris_Bettencourt/css/Notebookstyle.css&direction=cur&action=raw&ctype=text/css" />--> | ||
| + | </head> | ||
| + | <body> | ||
| + | <div id ="tbnote"> | ||
| + | <h2> Drug Screening </h2> | ||
| + | <h3> Day Number <sup>sup</sup> Month </h3> | ||
| + | <a href="https://2013.igem.org/Team:Paris_Bettencourt/Project/Trojan_Horse"> | ||
| + | <img src="https://static.igem.org/mediawiki/2013/0/00/PB_Trojan_Horse_logo.png" height="30px" width="30px"> | ||
</a> | </a> | ||
| - | <b> | + | <p><b>sRNA design</b></p> |
| - | + | <img src="https://static.igem.org/mediawiki/2013/4/4d/PB_TH_sRNA_Design.png" | |
| - | </ | + | width="304" height="228" |
| - | < | + | alt="sRNA Design"><br /> |
| - | + | <br /> | |
| + | Red sequences:<br /> | ||
| + | <br /> | ||
| + | pACYCDuet-1 (CmR) : <span style="color:red">ATATCCAGTGATTTTTTTCTCCAT</span><br /> | ||
| + | pCOLADuet-1 (KanR) : <span style="color:red">CGTTTCCCGTTGAATATGGCTCAT</span><br /> | ||
| + | <br /> | ||
| + | We decided that targeting only two different antibiotic resistance will be enough for a proof of concept. We give up AmpR because otherwise they might be experimental issues with AmpR that is also on phagemid <em>litmus28i</em>. | ||
</p> | </p> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
</div> | </div> | ||
| + | </body> | ||
| + | </html> | ||
Latest revision as of 02:09, 30 July 2013
Drug Screening
Day Number sup Month
sRNA design
Red sequences:
pACYCDuet-1 (CmR) : ATATCCAGTGATTTTTTTCTCCAT
pCOLADuet-1 (KanR) : CGTTTCCCGTTGAATATGGCTCAT
We decided that targeting only two different antibiotic resistance will be enough for a proof of concept. We give up AmpR because otherwise they might be experimental issues with AmpR that is also on phagemid litmus28i.
